Role of kidney injury molecule 1 and nephrin as biomarkers for diagnosis of nephropathy in type 2 diabetes mellitus

Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Assiut University Experience

Study of The Podocalyxin as An Early Marker for Diabetic Nephropathy and Its Correlation with Stages of Diabetic Nephropathy in A Sample of Egyptian Patients with T2DM

EVALUATION OF ANGIOPOIETIN-2 AS AN EARLY MARKER FOR DIABETIC NEPHROPATHY INZAGAZIG UNIVERSITY HOSPITALS

Does Podocyte-Associated Protein Has A Role in Early Detection of Diabetic Nephropathy in Type 2 Diabetes Mellitus?

Role of Kidney Injury Molecule-1 and β2-Microglobulin in Early Diagnosis of Diabetic Nephropathy

FETUIN A AS AN EARLY MARKER OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Serum suPAR and Urinary Nephrin as Novel Sensitive and Specific Markers for Diabetic Nephropathy in Patients with Type 2 DM

Serum and Urine Neutrophil Gelatinase- Associated Lipocalin: As an Indicator for Early Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients

Study of the association of serum level of nesfatin-1 and diabetic kidney disease in patients with type 2 diabetes